HEM:CC Message Board Post 6602234 | Hemostemix Inc.
home / stock / hem:cc / hem:cc message board
daniisable80
Member
Posted on: Apr/14/2023 07:54:15
Source: mwn
Hemostemix Inc. ($HEM) The company is also listed on the TSX Venture Exchange. This is a positive development for investors, as it will allow them to access shares of the company on a public market. Additionally, Hemostemix has received regulatory approval to begin clinical trials in both Canada and the United States, further underscoring its potential for long-term growth. The stock $HEM is trading with a market cap of $13.7 million + over the TSX-V.
News, Short Squeeze, Breakout and More Instantly...
-
Calgary, Alberta--(Newsfile Corp. - June 11, 2024) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it was notified by the World Intellectual Property Organization that it was granted the trademark Your Fountain of Youth by the Swiss Trademark Office. "In four h...
-
2024-06-03 13:23:23 ET In a press release this morning, %Hemostemix Inc. (TSXV: $HEM) (OTC: $HMTXF) announced it had signed a Letter of Intent ("LOI") with CytoImmune Therapeutics. The LOI will re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art clinical cell manu...
-
Calgary, Alberta--(Newsfile Corp. - June 3, 2024) - Hemostemix Inc. (TSXV: HEM) (OTC Pink: HMTXF) (FSE: 2VF0) is pleased to announce it has signed a Letter of Intent ("LOI") with CytoImmune Therapuetics ("CytoImmune") to re-establish production of ACP-01 ("ACP") in CytoImmune's state-of-the-art c...